Discovery and biological evaluation of new selective acetylcholinesterase inhibitors with anti-Aβ aggregation activity through molecular docking-based virtual screening release_2vcfcrp7qzesvgtw7k7rwuunpy

by Guangpu Liu, Yang Jiao, Yongqiang Lin, Haifang Hao, Yanli Dou, Juan Yang, Cheng-Shi Jiang, Ping Chang

Published in Chemical and pharmaceutical bulletin by Pharmaceutical Society of Japan.

2019   Volume 68, Issue 2, p161-166

Abstract

Discovery of novel multifunctional inhibitors targeting acetylcholinesterase (AChE) has becoming a hot spot in anti-Alzheimer's disease (AD) drug development. In the present study, four potent small molecule inhibitors (A01, A02, A03 and A04) of AChE with new chemical scaffold were identified. Inhibitor A03 displayed the most potent inhibition activity on AChE at enzymatic level with IC50 value of 180 nM, and high selectivity towards AChE over butyrylcholinesterase (BChE) by more than 100-fold. The binding modes of compounds A01-A04 were carefully analyzed by molecular docking and molecular dynamics (MD) simulation to provide informative clues for further structure modification. Finally, the anti-amyloid beta (Aβ) aggregation and neuroprotective activity were also well investigated. Our findings highlighted the therapeutic promise of AChE inhibitors A01-A04 for AD treatment.
In text/plain format

Archived Files and Locations

application/pdf  2.1 MB
file_bgtu5hjnmvhzzmdnzld5oojypy
www.jstage.jst.go.jp (repository)
web.archive.org (webarchive)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2019-12-07
Language   en ?
Container Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  0009-2363
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 44180acd-99a2-4446-bb08-4b6fea4633a2
API URL: JSON